Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Clinical therapeutics in feline medicine: updates for old and new drugs.
Journal: Journal of feline medicine and surgery
Published: October 06, 2025
Efficacy and Safety of Non-Insulin Antidiabetic Drugs in Cats: A Systematic Review.
Journal: Animals : an open access journal from MDPI
Published: July 14, 2025
Cycloadditions as a Sweet Route to 'Double C-Glycosylation'.
Journal: Biomolecules
Published: May 14, 2025
Bexagliflozin on Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Cureus
Published: April 17, 2025
A renal indication for semaglutide (Ozempic).
Journal: The Medical letter on drugs and therapeutics
Published: February 26, 2025
Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials.
Journal: Systematic reviews
Published: October 29, 2024
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials.
Journal: Frontiers in pharmacology
Published: October 25, 2024
Sodium-glucose co-transporter 2 inhibitors: a pleiotropic drug in humans with promising results in cats.
Journal: Frontiers in veterinary science
Published: August 14, 2024
Novel FDA-approved bexagliflozin drug for treating type 2 diabetes mellitus.
Journal: Annals of medicine and surgery (2012)
Published: June 19, 2024
SGLT2 inhibitor use in the management of feline diabetes mellitus.
Journal: Journal of veterinary pharmacology and therapeutics
Published: February 23, 2024
Bexagliflozin.
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: January 17, 2024
Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin.
Journal: Diabetes, obesity & metabolism
Published: November 08, 2023
Last Updated: 10/31/2025